Drugs / 3-HYDROXYBUTYRIC ACID, (+/-)-
3-HYDROXYBUTYRIC ACID, (+/-)-
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02471040 | May 2013 → Apr 2022 | hypoglycemia, type 1 diabetes mellitus | Yale University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT03560323 Comparator | Jan 2019 → Aug 2024 | heart failure, type 2 diabetes mellitus | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| Phase 1/2 | NCT06351124 Comparator | Aug 2024 → Apr 2025 overdue | Crohn disease | University of Texas at Austin | Recruiting | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3-HYDROXYBUTYRIC ACID, (+/-)- | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | .beta.-hydroxybutyric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | 3-hydroxybutanoate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | Beta-hydroxybutyrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02471040 ↗ |
| Known as | BHB | “ketone body supplement beta-hydroxybutyrate (BHB) for 4 weeks” NCT06351124 ↗ |
| Known as | D,l-3 hydroxybutyrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | D,l-3-hydroxybutyric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | Hydroxybutyric acid, dl- | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Known as | NSC-3806 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1162496 ↗ |
| Modality | Small molecule | — CHEMBL1162496 ↗ |